These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 29031499)
1. MicroRNAs 15A and 16-1 Activate Signaling Pathways That Mediate Chemotaxis of Immune Regulatory B cells to Colorectal Tumors. Liu R; Lu Z; Gu J; Liu J; Huang E; Liu X; Wang L; Yang J; Deng Y; Qian J; Luo F; Wang Z; Zhang H; Jiang X; Zhang D; Qian J; Liu G; Zhu H; Qian Y; Liu Z; Chu Y Gastroenterology; 2018 Feb; 154(3):637-651.e7. PubMed ID: 29031499 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1. He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514 [TBL] [Abstract][Full Text] [Related]
3. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571 [TBL] [Abstract][Full Text] [Related]
4. A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells. Liu S; Sun X; Wang M; Hou Y; Zhan Y; Jiang Y; Liu Z; Cao X; Chen P; Liu Z; Chen X; Tao Y; Xu C; Mao J; Cheng C; Li C; Hu Y; Wang L; Chin YE; Shi Y; Siebenlist U; Zhang X Gastroenterology; 2014 Oct; 147(4):847-859.e11. PubMed ID: 24931456 [TBL] [Abstract][Full Text] [Related]
5. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice. Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057 [TBL] [Abstract][Full Text] [Related]
6. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice. Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860 [TBL] [Abstract][Full Text] [Related]
7. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice. Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235 [TBL] [Abstract][Full Text] [Related]
8. IL-17 inhibits CXCL9/10-mediated recruitment of CD8 Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909 [TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. Wang D; Fu L; Sun H; Guo L; DuBois RN Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008 [TBL] [Abstract][Full Text] [Related]
10. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression. Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398 [TBL] [Abstract][Full Text] [Related]
11. GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2. Li ZW; Sun B; Gong T; Guo S; Zhang J; Wang J; Sugawara A; Jiang M; Yan J; Gurary A; Zheng X; Gao B; Xiao SY; Chen W; Ma C; Farrar C; Zhu C; Chan OTM; Xin C; Winnicki A; Winnicki J; Tang M; Park R; Winnicki M; Diener K; Wang Z; Liu Q; Chu CH; Arter ZL; Yue P; Alpert L; Hui GS; Fei P; Turkson J; Yang W; Wu G; Tao A; Ramos JW; Moisyadi S; Holcombe RF; Jia W; Birnbaumer L; Zhou X; Chu WM Gastroenterology; 2019 Jun; 156(8):2297-2312. PubMed ID: 30836096 [TBL] [Abstract][Full Text] [Related]
12. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice. Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138 [TBL] [Abstract][Full Text] [Related]
14. Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1. Öner MG; Rokavec M; Kaller M; Bouznad N; Horst D; Kirchner T; Hermeking H Gastroenterology; 2018 Dec; 155(6):1868-1882. PubMed ID: 30099074 [TBL] [Abstract][Full Text] [Related]
15. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice. Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569 [TBL] [Abstract][Full Text] [Related]
16. MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment. Lu Y; Li Y; Liu Q; Tian N; Du P; Zhu F; Han Y; Liu X; Liu X; Peng X; Wang X; Wu Y; Tong L; Li Y; Zhu Y; Wu L; Zhang P; Xu Y; Chen H; Li B; Tong X Gastroenterology; 2021 Aug; 161(2):575-591.e16. PubMed ID: 33901495 [TBL] [Abstract][Full Text] [Related]
17. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon. Rigby RJ; Simmons JG; Greenhalgh CJ; Alexander WS; Lund PK Oncogene; 2007 Jul; 26(33):4833-41. PubMed ID: 17297444 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑16 inhibits interleukin‑13‑induced inflammatory cytokine secretion and mucus production in nasal epithelial cells by suppressing the IκB kinase β/nuclear factor‑κB pathway. Gao Y; Yu Z Mol Med Rep; 2018 Oct; 18(4):4042-4050. PubMed ID: 30132525 [TBL] [Abstract][Full Text] [Related]
19. Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells. Rizzo A; De Mare V; Rocchi C; Stolfi C; Colantoni A; Neurath MF; Macdonald TT; Pallone F; Monteleone G; Fantini MC Carcinogenesis; 2014 Jul; 35(7):1536-46. PubMed ID: 24480808 [TBL] [Abstract][Full Text] [Related]
20. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice. Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]